Institut des Maladies Neurodégénératives (IMN)

L’Institut des Maladies Neurodégénératives (IMN) (UMR 5293) est une Unité Mixte de Recherche associant l’Université de Bordeaux et le CNRS. Il regroupe 11 équipes de recherches fondamentale et préclinique et d’une équipe de Recherche clinique adossée au CHU de Bordeaux. L’IMN associe recherche fondamentale, préclinique et clinique dans le but de :

-Développer de nouvelles approches thérapeutiques des maladies neurodégénératives en facilitant la recherche translationnelle du laboratoire au lit du patient.

-D’accroître sa visibilité et son attractivité dans le champ des neurosciences translationnelles (Maladie de Parkinson et syndromes parkinsoniens atypiques, maladie d’Alzheimer, troubles obsessionnels compulsifs, etc.) et fondamentales (planification, cognition, contrôle moteur, substrats moléculaires de la transmission synaptique) en s’appuyant sur le potentiel de ses équipes et la dynamique mise en place depuis sa création.

Site Web

Lien scanR

	2020	2021	2022	2023	2024
Actes de congrès/Proceedings	0	0	0	0	0
Article de blog scientifique	0	0	0	0	0
Article de revue	5	12	12	18	4
Autre document	0	0	0	0	0
Brevet	0	0	0	0	0
Chapitre d'ouvrage	0	0	0	0	0
Communication dans un congrès	0	0	0	0	0
Document de travail - Pré-publication	0	0	0	1	0
HDR	0	0	0	0	0
Notice d'encyclopédie ou de dictionnaire	0	0	0	0	0
N°spécial de revue/special issue	0	0	0	0	0
Ouvrage	0	0	0	0	0
Poster	0	0	0	0	0
Rapport	0	0	0	0	0
Thèse d'exercice	0	0	0	0	0
Thèses de doctorat	3	4	2	0	0
Traduction	0	0	0	0	0

Institut des Maladies Neurodégénératives (IMN) - UMR 5293

Parcourir par

Dépôts récents

Lifespan neurodegeneration of the human brain in multiple sclerosis

Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders

Recent Advances in Clinical Trials in Multiple System Atrophy

Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries

Anatomical MRI staging of frontotemporal dementia variants

Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan

Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening

Usefulness of thalamic beta activity for closed-loop therapy in essential tremor

Identification of circulating proteins associated with general cognitive function among middle-aged and older adults

Retinal microvasculature and incident dementia over 10 years: The Three-City-Alienor cohort

Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study

Understanding factors associated with the trajectory of subjective cognitive complaints in groups with similar objective cognitive trajectories

GRK2‐ Targeted Knockdown as Therapy for Multiple System Atrophy

Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization

Developmental expression of ectonucleotidase and purinergic receptors detection by whole-mount in situ hybridization in Xenopus embryos

Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort

Association of retinal nerve layers thickness and brain imaging in healthy young subjects from the i-Share-Bordeaux study

Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates

Impact of dietary vitamin A on striatal function in adult rats

White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis

Statistiques

Statistiques générales de la collection

Nombre de documents par année

Dépôs récents

Institut des Maladies Neurodégénératives (IMN) - UMR 5293

Parcourir par

Dépôts récents

Lifespan neurodegeneration of the human brain in multiple sclerosis ﻿

Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders ﻿

Recent Advances in Clinical Trials in Multiple System Atrophy ﻿

Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries ﻿

Anatomical MRI staging of frontotemporal dementia variants ﻿

Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan ﻿

Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening ﻿

Usefulness of thalamic beta activity for closed-loop therapy in essential tremor ﻿

Identification of circulating proteins associated with general cognitive function among middle-aged and older adults ﻿

Retinal microvasculature and incident dementia over 10 years: The Three-City-Alienor cohort ﻿

Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study ﻿

Understanding factors associated with the trajectory of subjective cognitive complaints in groups with similar objective cognitive trajectories ﻿

GRK2‐ Targeted Knockdown as Therapy for Multiple System Atrophy ﻿

Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization ﻿

Developmental expression of ectonucleotidase and purinergic receptors detection by whole-mount in situ hybridization in Xenopus embryos ﻿

Physical activity, biomarkers of brain pathologies and dementia risk: Results from the Memento clinical cohort ﻿

Association of retinal nerve layers thickness and brain imaging in healthy young subjects from the i-Share-Bordeaux study ﻿

Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates ﻿

Impact of dietary vitamin A on striatal function in adult rats ﻿

White-matter-nulled MPRAGE at 7T reveals thalamic lesions and atrophy of specific thalamic nuclei in multiple sclerosis ﻿